Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125228191 | 12522819 | 1 | I | 20160617 | 20160701 | 20160701 | EXP | CA-HQ SPECIALTY-CA-2016INT000433 | INTERCHEM | 63.00 | YR | F | Y | 0.00000 | 20160701 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125228191 | 12522819 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | MORE THAN 20 MG (1 IN 1 W) | 201749 | |||||||||||
| 125228191 | 12522819 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 125228191 | 12522819 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 2 G (1 G, 2 IN 1 D) | 0 | 1 | G | ||||||||
| 125228191 | 12522819 | 4 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | UNK | 0 | |||||||||||
| 125228191 | 12522819 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 20 MG, 1 D | 0 | 20 | MG | |||||||||
| 125228191 | 12522819 | 6 | SS | REMICADE | INFLIXIMAB | 1 | UNK | 0 | |||||||||||
| 125228191 | 12522819 | 7 | SS | HUMIRA | ADALIMUMAB | 1 | UNK | 0 | |||||||||||
| 125228191 | 12522819 | 8 | SS | STELARA | USTEKINUMAB | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125228191 | 12522819 | 1 | Rheumatoid arthritis |
| 125228191 | 12522819 | 2 | Rheumatoid arthritis |
| 125228191 | 12522819 | 3 | Rheumatoid arthritis |
| 125228191 | 12522819 | 4 | Product used for unknown indication |
| 125228191 | 12522819 | 5 | Product used for unknown indication |
| 125228191 | 12522819 | 6 | Product used for unknown indication |
| 125228191 | 12522819 | 7 | Product used for unknown indication |
| 125228191 | 12522819 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125228191 | 12522819 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125228191 | 12522819 | Drug intolerance | |
| 125228191 | 12522819 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125228191 | 12522819 | 1 | 2005 | 0 | ||
| 125228191 | 12522819 | 4 | 2005 | 0 |